These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 11791171
21. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells. Hopkins-Donaldson S, Yan P, Bourloud KB, Muhlethaler A, Bodmer JL, Gross N. Oncogene; 2002 Sep 05; 21(39):6132-7. PubMed ID: 12203125 [Abstract] [Full Text] [Related]
22. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. Minko T, Paranjpe PV, Qiu B, Lalloo A, Won R, Stein S, Sinko PJ. Cancer Chemother Pharmacol; 2002 Aug 05; 50(2):143-50. PubMed ID: 12172980 [Abstract] [Full Text] [Related]
23. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG, de Jong S. Gynecol Oncol; 2005 May 05; 97(2):353-64. PubMed ID: 15863130 [Abstract] [Full Text] [Related]
24. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2. Wu GS, El-Deiry WS. Clin Cancer Res; 1996 Apr 05; 2(4):623-33. PubMed ID: 9816212 [Abstract] [Full Text] [Related]
25. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Du J, Chen GG, Vlantis AC, Chan PK, Tsang RK, van Hasselt CA. Cancer Lett; 2004 Mar 08; 205(1):81-8. PubMed ID: 15036664 [Abstract] [Full Text] [Related]
26. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Anthoney DA, McIlwrath AJ, Gallagher WM, Edlin AR, Brown R. Cancer Res; 1996 Mar 15; 56(6):1374-81. PubMed ID: 8640828 [Abstract] [Full Text] [Related]
27. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ. Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810 [Abstract] [Full Text] [Related]
28. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Bush JA, Cheung KJ, Li G. Exp Cell Res; 2001 Dec 10; 271(2):305-14. PubMed ID: 11716543 [Abstract] [Full Text] [Related]
29. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]. Song Y, Shen K, Yu JR. Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307 [Abstract] [Full Text] [Related]
30. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY. Biochem Pharmacol; 2004 Jul 15; 68(2):293-303. PubMed ID: 15194001 [Abstract] [Full Text] [Related]
31. Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event. Essmann F, Engels IH, Totzke G, Schulze-Osthoff K, Jänicke RU. Cancer Res; 2004 Oct 01; 64(19):7065-72. PubMed ID: 15466201 [Abstract] [Full Text] [Related]
32. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Liu X, Yue P, Khuri FR, Sun SY. Cancer Res; 2005 Oct 15; 65(20):9169-75. PubMed ID: 16230375 [Abstract] [Full Text] [Related]
33. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Yang X, Fraser M, Moll UM, Basak A, Tsang BK. Cancer Res; 2006 Mar 15; 66(6):3126-36. PubMed ID: 16540663 [Abstract] [Full Text] [Related]
34. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3'-kinase inhibition in the KM20 human colon cancer cell line. Wang Q, Li N, Wang X, Kim MM, Evers BM. Clin Cancer Res; 2002 Jun 15; 8(6):1940-7. PubMed ID: 12060639 [Abstract] [Full Text] [Related]
35. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Baptiste N, Friedlander P, Chen X, Prives C. Oncogene; 2002 Jan 03; 21(1):9-21. PubMed ID: 11791172 [Abstract] [Full Text] [Related]
36. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M, Ikejima T. Acta Pharmacol Sin; 2007 Jul 03; 28(7):1057-66. PubMed ID: 17588343 [Abstract] [Full Text] [Related]
37. E2F activity is essential for survival of Myc-overexpressing human cancer cells. Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J. Oncogene; 2002 Sep 19; 21(42):6498-509. PubMed ID: 12226753 [Abstract] [Full Text] [Related]
38. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW, Chong SY, Kim JY, Eom JI, Jeung HK, Maeng HY, Lee ST, Min YH. Clin Cancer Res; 2003 Oct 15; 9(13):5018-27. PubMed ID: 14581377 [Abstract] [Full Text] [Related]
39. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells. Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, Choi YH. Oncol Rep; 2008 Feb 15; 19(2):517-26. PubMed ID: 18202802 [Abstract] [Full Text] [Related]
40. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling. Perchellet EM, Wang Y, Weber RL, Sperfslage BJ, Lou K, Crossland J, Hua DH, Perchellet JP. Biochem Pharmacol; 2004 Feb 01; 67(3):523-37. PubMed ID: 15037204 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]